Sonia Del Barco

2.3k total citations
50 papers, 1.4k citations indexed

About

Sonia Del Barco is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sonia Del Barco has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Sonia Del Barco's work include Cancer Treatment and Pharmacology (12 papers), Glioma Diagnosis and Treatment (10 papers) and HER2/EGFR in Cancer Research (10 papers). Sonia Del Barco is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Glioma Diagnosis and Treatment (10 papers) and HER2/EGFR in Cancer Research (10 papers). Sonia Del Barco collaborates with scholars based in Spain, France and United Kingdom. Sonia Del Barco's co-authors include Begoña Martı́n-Castillo, Cristina Oliveras‐Ferraros, Alejandro Vázquez‐Martín, Javier A. Menéndez, Sílvia Cufí, Joaquim Bosch‐Barrera, Jorge Joven, Eugeni López‐Bonet, Carlos Jara and Maria Martinez‐García and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Sonia Del Barco

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonia Del Barco Spain	18	821	778	434	230	167	50	1.4k
Shuko Harada United States	22	604 0.7×	399 0.5×	297 0.7×	293 1.3×	195 1.2×	101	1.4k
Qi Xue China	13	1.0k 1.3×	300 0.4×	391 0.9×	353 1.5×	154 0.9×	34	1.5k
JiHoon Kang South Korea	21	642 0.8×	493 0.6×	476 1.1×	275 1.2×	133 0.8×	63	1.4k
Nirosha Suraweera United Kingdom	17	631 0.8×	581 0.7×	494 1.1×	153 0.7×	182 1.1×	23	1.5k
Hao‐Wei Teng Taiwan	21	576 0.7×	788 1.0×	270 0.6×	254 1.1×	189 1.1×	73	1.4k
Fei Cao China	20	600 0.7×	333 0.4×	306 0.7×	254 1.1×	239 1.4×	77	1.4k
Manuel Picon‐Ruiz Spain	14	687 0.8×	783 1.0×	486 1.1×	148 0.6×	69 0.4×	20	1.5k
Man‐Hsin Hung Taiwan	21	537 0.7×	488 0.6×	232 0.5×	273 1.2×	119 0.7×	45	1.4k
Dayong Zheng China	19	835 1.0×	476 0.6×	517 1.2×	331 1.4×	149 0.9×	62	1.5k

Countries citing papers authored by Sonia Del Barco

Since Specialization

Citations

This map shows the geographic impact of Sonia Del Barco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Del Barco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Del Barco more than expected).

Fields of papers citing papers by Sonia Del Barco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Del Barco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Del Barco. The network helps show where Sonia Del Barco may publish in the future.

Co-authorship network of co-authors of Sonia Del Barco

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Del Barco. A scholar is included among the top collaborators of Sonia Del Barco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Del Barco. Sonia Del Barco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petrova, Dafina, Daniel Redondo‐Sánchez, Miguel Rodríguez‐Barranco, et al.. (2024). Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain. BMJ Quality & Safety. 34(12). 810–823. 1 indexed citations

Salgado, María Ángeles Vaz, Sonia Del Barco, Juan Manuel Sepúlveda-Sánchez, et al.. (2023). 501O Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial. Annals of Oncology. 34. S393–S393. 1 indexed citations

Salgado, María Ángeles Vaz, Regina Gironés, Sonia Del Barco, et al.. (2022). Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial.. Journal of Clinical Oncology. 40(16_suppl). 2060–2060. 1 indexed citations

Hernández, Ainhoa, Ana M Muñoz‐Mármol, Anna Esteve‐Codina, et al.. (2022). In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma. Scientific Reports. 12(1). 14439–14439. 2 indexed citations

Luque, Raquel, Manuel Benavides, Sonia Del Barco, et al.. (2021). SEOM clinical guideline for management of adult medulloblastoma (2020). Clinical & Translational Oncology. 23(5). 940–947. 7 indexed citations

Balañá, Carmen, María Buxó, Gerard Blasco, et al.. (2019). Impact of Dexamethasone on Metabolic Profile and Survival in Glioblastoma. Universitat de Girona Digital Repository (Universitat de Girona). 4(1). 2 indexed citations

Blancas, Isabel, Elena Aguirre, Serafín Morales, et al.. (2018). Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens. Clinical & Translational Oncology. 21(4). 459–466. 10 indexed citations

Barco, Sonia Del, et al.. (2017). A Case Report of a Patient with HER2-Positive Metastatic Breast Cancer on Dialysis, Who Responded to Ado- Trastuzumab Emtansine. 2(1). 3 indexed citations

Solans, Marta, Aina Roca-Barceló, L. Vilardell, et al.. (2017). Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994–2013). Cancer Epidemiology. 50(Pt A). 1–8. 28 indexed citations

10.

Martinez‐García, Maria, Estela Pineda, Sonia Del Barco, et al.. (2016). Feasibility and efficacy of concomitant chemoradiation (Ch-RT) in the management of newly diagnosed elderly glioblastoma (GB) patients: Results from the GLIOCAT study.. Journal of Clinical Oncology. 34(15_suppl). 2045–2045.

11.

Martínez-Jáñez, Noelia, Ana De Juan, Luis de la Cruz‐Merino, et al.. (2016). Anti-HER2 Therapy Beyond Second-Line for HER2- Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel. Breast Care. 11(2). 133–138. 2 indexed citations

12.

Estival, Anna, Estela Pineda, Maria Martinez‐García, et al.. (2016). MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study. Annals of Oncology. 27. vi107–vi107. 1 indexed citations

13.

Barco, Sonia Del, et al.. (2013). SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013. Clinical & Translational Oncology. 15(12). 1011–1017. 8 indexed citations

14.

Bermejo, Begoña, Amparo Ruı́z, Manuel Ruíz Borrego, et al.. (2013). Randomized phase III study of adjuvant chemotherapy for node-positive early breast cancer (BC) patients (pts) comparing epirubicin plus cyclophosphamide followed by docetaxel (EC-T) versus epirubicin plus docetaxel followed by capecitabine (ET-X): Efficacy analysis of the GEICAM/2003-10 trial.. Journal of Clinical Oncology. 31(15_suppl). 1027–1027. 2 indexed citations

15.

Oliveras‐Ferraros, Cristina, Alejandro Vázquez‐Martín, Sílvia Cufí, et al.. (2011). Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapies. Biochemical and Biophysical Research Communications. 407(2). 412–419. 37 indexed citations

16.

Oliveras‐Ferraros, Cristina, Sílvia Cufí, Alejandro Vázquez‐Martín, et al.. (2011). Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a. Cell Cycle. 10(7). 1144–1151. 94 indexed citations

17.

Vázquez‐Martín, Alejandro, Cristina Oliveras‐Ferraros, Sonia Del Barco, Begoña Martı́n-Castillo, & Javier A. Menéndez. (2010). The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Research and Treatment. 126(2). 355–364. 145 indexed citations

18.

Guerrero, Antonio, Álvaro Rodríguez-Lescure, Lourdes Calvo, et al.. (2010). Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer. Anti-Cancer Drugs. 22(3). 283–289. 4 indexed citations

19.

Reck, Martin, Sonia Del Barco, Paul Cornes, et al.. (2008). Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma. Lung Cancer. 64(3). 319–325. 17 indexed citations

20.

Brunet, Joan, Sonia Del Barco, Alexandra Garcia, et al.. (2006). Access to specialized cancer care and clinical trials for cancer patients from non-urban areas is facilitated by a Cancer Network organization. Journal of Clinical Oncology. 24(18_suppl). 16006–16006. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact